AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 587 businesses audited.
Medical Devices, Pharma & Biotech BS: ALUNBRIG (Takeda Pharmaceutical Company) (alunbrig.com)
This is a high-substance clinical site that uses patient storytelling as a bridge to complex trial data. It contains the minimum amount of fluff allowed by modern pharmaceutical marketing standards. The score is only elevated from ‘Minimal’ to ‘Low’ due to the technical absence of direct outbound links to peer-reviewed sources in the crawled text snippets and the use of testimonials for efficacy signaling.
Integrate direct outbound links to the New England Journal of Medicine or Lancet Oncology publications for the ALTA trial data. Add a clear disclaimer beneath patient testimonial videos stating that ‘individual results may vary’ to separate anecdotal hope from statistical clinical probability. Include a ClinicalTrials.gov ID (NCT number) directly in the sub-page headings for maximum transparency. Replace the ‘Review Count’ schema with ‘Patient Story’ markers to avoid the appearance of trust theatre.
Information density is exceptionally high for a public-facing website. The body text is saturated with specific clinical metrics such as the 74% tumor shrinkage rate vs 62% for crizotinib and a median progression-free survival of 24 months. Headings are functional rather than promotional, though there is necessary repetition of the drug’s indication for regulatory compliance. Power words are almost entirely absent, replaced by technical nouns like kinase inhibitor and brain metastases.
A site without a coherent link graph forces AI to guess which pages matter. Reveal your real semantic graph and see how your domain is actually mapped by machine logic.
There is virtually zero semantic drift between the homepage and sub-pages. The homepage establishes the drug’s primary signal for ALK+ mNSCLC, and sub-pages (efficacy and resistance) deliver deep-dive data supporting both first-line and second-line treatment paths. The internal logic remains consistent: a once-daily pill backed by Blinded Independent Review Committee results.
Move beyond vague agency reporting and visualize your surgical implementation plan. Order an Executive SEO Strategy and stop relying on superficial keyword tracking.
The site triggers trust theatre flags because it lists review_count (1 to 6) without external proof_links in the metadata, a common byproduct of pharma websites hosting patient testimonials. While the clinical claims are substantiated by study names like ALTA 1L, the use of individual patient videos (Eric, Greg, Katie) to frame efficacy results like ‘complete metabolic response’ creates a minor credibility gap where anecdotal evidence is used to soften hard clinical data. The trust_theatre_flag is true on all 4 pages, accounting for the majority of points in this pillar.
Proof density is very high, with specific patient counts (275 total in the ALTA 1L study), age ranges (27 to 89), and objective metrics (N.E.D. status) provided. The ratio of verifiable evidence to vague assertions is roughly 8:1, with the only vague points being found in the emotive sections of patient testimonials.
To examine how structural entropy affects chunking and retrieval, review the Moz Semantic HTML audit. View the Moz Semantic HTML Audit for a complete example of heading logic, landmark integrity, and DOM depth diagnostics.
The site follows a rigid pharmaceutical template (ISI, Patient Stories, Dosing, Resources) which is industry-standard rather than generic BS. Cliché usage is low, though terms like ‘where science meets compassion’ and ‘hope’ are utilized in patient transcripts. The value proposition is entirely unique as it refers to a specific, patented chemical compound, making it impossible to ‘copy-paste’ onto a competitor without violating FDA and patent laws.
Authority is well-established through robust MedicalWebPage schema that correctly identifies the drug’s non-proprietary name (brigatinib) and specialty (oncologic). The ‘named experts’ are patients rather than physicians, but their roles are clearly defined as personal experiences rather than clinical endorsements. Technical implementation is clean with a valid heading hierarchy and sophisticated structured data.
There is no disconnect between marketing tone and substance. When the site claims the drug ‘helped shrink tumors in the brain,’ it immediately follows with specific sample sizes (41 patients) and percentage responses (78% vs 26%). This level of forensic granularity is the antithesis of bullshit.
Medical Devices, Pharma & Biotech BS: ALUNBRIG (Takeda Pharmaceutical Company) (alunbrig.com)
The site perfectly aligns with the Pharma & Biotech industry, specifically the oncology sub-sector. The content is heavily regulated, focusing on a specific FDA-approved molecular entity (brigatinib) with mandatory safety disclosures and clinical trial data.
Every retrieval error rooted in "wrong page surfaced" begins with one failure: unstable URL identity. Read the URL & Canonical Technical Guide to learn how consistent paths and canonical alignment preserve semantic cohesion.
“The score of 18 is driven primarily by the trust_and_proof pillar (8 points) due to the presence of unverified testimonial counts in the schema and anecdotal efficacy claims. Information density and authority gaps are nearly zero, reflecting the highly technical and regulated nature of the product. The site is a benchmark for low-BS communication in the pharma sector.”